Johnson & Johnson’s Fast-Acting Depression Drug Is Approved

6:58am PST - March 6th, 2019    ketamine - Fortune

The FDA greenlighted Johnson & Johnson’s nasal spray Spravato, a close chemical cousin of the anesthetic ketamine.